M. Qiu

发表

Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification

Xiaoying Li, M. Qiu, K. Na, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of 6‐ versus 12‐month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4‐year results of the I LOVE IT 2 study

M. Qiu, K. Na, Sicong Ma, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of extended dual antiplatelet therapy on clinical prognosis in acute coronary syndrome patients with intermediate or high ischemic risk defined by the GRACE score

M. Qiu, Sicong Ma, Z. Qi, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of dual antiplatelet therapy duration on 1‐year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real‐world OPT‐CAD study

M. Qiu, Jing Li, Yi Li, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of six versus 12 months of dual antiplatelet therapy in patients with drug‐eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I‐LOVE‐IT 2 trial

M. Qiu, Jing Li, Yi Li, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study

M. Qiu, Sicong Ma, Yi Li, 2020, Advances in Therapy.

Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real‐world study

Xiying Liu, M. Qiu, K. Na, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of Ticagrelor vs. Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention After Risk Stratification With the CHA2DS2-VASc Score

M. Qiu, K. Na, Sicong Ma, 2022, Frontiers in Cardiovascular Medicine.

Percutaneous coronary intervention in patients with acute coronary syndrome in Chinese Military Hospitals, 2011–2014: a retrospective observational study of a national registry

M. Qiu, Yi Li, Yaling Han, 2018, BMJ Open.

Impacts of anemia on 3-year ischemic events in patients undergoing percutaneous coronary intervention: a propensity-matched study.

M. Qiu, Jing Li, Yi Li, 2015, Journal of thoracic disease.

Impact of anemia on long-term ischemic events and bleeding events in patients undergoing percutaneous coronary intervention: a system review and meta-analysis.

M. Qiu, Jing Li, Yi Li, 2015, Journal of thoracic disease.

Long-term prognosis of patients with coronary heart disease and mild to moderate renal dysfunction after implantation of biodegradable polymer or durable polymer-coated drug-eluting stents — insight from the I-LOVE-IT 2 trial

M. Qiu, Jing Li, Yi Li, 2018 .

Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors

Yaling Han, M. Qiu, K. Na, 2022, Clinical Research in Cardiology.

Predictors and long‐term outcomes of in‐hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention

M. Qiu, K. Na, Yuzhuo Li, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention

M. Qiu, K. Na, Yuzhuo Li, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction

G. Stone, Yaling Han, Chenghui Yan, 2021, Frontiers in Cardiovascular Medicine.

Determination of Optimal Fluoroscopic Angulations for Left Main Coronary Artery Ostial Interventions: 3-Dimensional Computed Tomography Validation

G. Mintz, M. Qiu, Yi Li, 2022, Journal of interventional cardiology.

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Y. Liu, G. Stone, Yan Li, 2022, The Lancet.

A Randomized Controlled Trial of a Biodegradable Polymer, Microcrystalline Sirolimus-Eluting Stent (MiStent) versus Another Biodegradable Polymer Sirolimus-Eluting Stent (TIVOLI): The DESSOLVE-C Trial

Yu Cao, M. Qiu, Sicong Ma, 2022, Cardiology Discovery.

Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study

M. Qiu, K. Na, Sicong Ma, 2022, Cardiovascular therapeutics.

Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction

Yaling Han, M. Qiu, K. Na, 2022, Frontiers in Immunology.